Brokerages Set Owens & Minor, Inc. (NYSE:OMI) Target Price at $23.29

Owens & Minor, Inc. (NYSE:OMI) has received an average recommendation of “Hold” from the eight analysts that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, six have given a hold recommendation and one has assigned a buy recommendation to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $23.29.

OMI has been the subject of a number of recent research reports. Citigroup boosted their price objective on shares of Owens & Minor from $23.00 to $24.00 and gave the company a “neutral” rating in a research report on Wednesday, February 21st. SVB Leerink began coverage on shares of Owens & Minor in a research note on Monday, February 26th. They set a “market perform” rating and a $24.00 target price for the company. TheStreet raised shares of Owens & Minor from a “d+” rating to a “c-” rating in a research note on Monday, March 4th. Leerink Partnrs reissued a “market perform” rating on shares of Owens & Minor in a research note on Monday, February 26th. Finally, Robert W. Baird boosted their target price on shares of Owens & Minor from $24.00 to $28.00 and gave the company a “neutral” rating in a research note on Wednesday, April 10th.

Insider Transactions at Owens & Minor

In other news, SVP Michael Wayne Lowry sold 10,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 27th. The shares were sold at an average price of $25.00, for a total value of $250,000.00. Following the completion of the sale, the senior vice president now directly owns 71,654 shares of the company’s stock, valued at approximately $1,791,350. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 3.59% of the company’s stock.

Institutional Trading of Owens & Minor

Several institutional investors and hedge funds have recently added to or reduced their stakes in OMI. Deerfield Management Company L.P. Series C lifted its stake in Owens & Minor by 35.6% during the third quarter. Deerfield Management Company L.P. Series C now owns 6,435,000 shares of the company’s stock valued at $103,990,000 after purchasing an additional 1,690,000 shares during the last quarter. FMR LLC lifted its stake in Owens & Minor by 10.6% during the third quarter. FMR LLC now owns 11,479,209 shares of the company’s stock valued at $185,504,000 after purchasing an additional 1,103,275 shares during the last quarter. Deutsche Bank AG lifted its stake in Owens & Minor by 278.0% during the third quarter. Deutsche Bank AG now owns 694,248 shares of the company’s stock valued at $11,219,000 after purchasing an additional 510,596 shares during the last quarter. Nuveen Asset Management LLC lifted its stake in Owens & Minor by 61.8% during the second quarter. Nuveen Asset Management LLC now owns 1,288,925 shares of the company’s stock valued at $24,541,000 after purchasing an additional 492,348 shares during the last quarter. Finally, Norges Bank acquired a new stake in Owens & Minor during the fourth quarter valued at approximately $9,160,000. 98.04% of the stock is owned by institutional investors and hedge funds.

Owens & Minor Price Performance

OMI opened at $24.79 on Monday. The company has a 50-day moving average of $24.90 and a 200-day moving average of $20.80. The company has a market capitalization of $1.90 billion, a P/E ratio of -45.90, a PEG ratio of 0.76 and a beta of 0.43. Owens & Minor has a 1-year low of $13.34 and a 1-year high of $28.35. The company has a debt-to-equity ratio of 2.05, a quick ratio of 0.52 and a current ratio of 1.11.

Owens & Minor (NYSE:OMI) last announced its quarterly earnings data on Tuesday, February 20th. The company reported $0.69 earnings per share for the quarter, beating analysts’ consensus estimates of $0.66 by $0.03. Owens & Minor had a negative net margin of 0.40% and a positive return on equity of 11.62%. The business had revenue of $2.66 billion during the quarter, compared to the consensus estimate of $2.67 billion. During the same quarter in the prior year, the firm earned $0.28 EPS. The company’s revenue for the quarter was up 4.1% compared to the same quarter last year. Equities analysts expect that Owens & Minor will post 1.54 EPS for the current fiscal year.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.